Mr. Richard Jay Troast, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 468 Manchester Ave, North Haledon, NJ 07508 Phone: 973-423-2179 |
News Archive
Clinical trials of new drugs to treat the most aggressive form of prostate cancer are expected to be underway in Brisbane within three years, thanks to Movember Revolutionary Team Award grant that is fast-tracking global research into the disease.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results today from a Phase 1 study comparing a dose-timing strategy of PA32540 and clopidogrel spaced 10 hours apart as compared to synchronous administration of enteric-coated (EC) omeprazole (40 mg), enteric-coated aspirin (81 mg) and clopidogrel.
The FDA is right - when it comes to disease culprits, cigarette smoking tops the list. While recognized as the number-one cause of preventable disease and death, it's an incredibly tough habit to break due to the addictiveness of nicotine.
HOYA Group's Vision Care Division, a key player in the global market for ophthalmic lenses, announces the start of HOYA Lens Romania.
Four cancer patients became the first in Latin America to receive treatment using a fast form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending modern care to more patients. Doctors at Hope International Centro de Radioterapia of Guatemala are now treating four patients using RapidArc® radiotherapy technology from Varian Medical Systems, one with recurring prostate cancer, one with a nasal cavity tumor, one with rectal cancer, and one with recurring glioblastoma multiforme-an aggressive type of brain tumor.
› Verified 4 days ago